PALU
Direxion Daily PANW Bull 2X SharesNASDAQ
Key Statistics
Market Cap
—
P/E Ratio
78.45
EPS
—
Beta
0.00
52W High
$27.24
52W Low
$9.80
50-Day MA
$13.39
200-Day MA
$20.47
Dividend Yield
0.00%
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Direxion Daily PANW Bull 2X Shares
Palatin Technologies, Inc. (PALU) is a biopharmaceutical firm focused on innovative therapeutic solutions for unmet medical needs, particularly in sexual health, reproductive health, and oncology. Its flagship product, Vyleesi, offers a novel treatment for hypoactive sexual desire disorder in premenopausal women, reflecting the company's commitment to addressing critical health challenges. With a robust pipeline of drug candidates and strategic partnerships aimed at bolstering R&D, Palatin is well-positioned for growth in the dynamic healthcare sector, thereby creating significant value for its investors.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | 0 |
| EBITDA | — |
| Operating Margin | 0.00% |
| Return on Equity | 0.00% |
| Return on Assets | 0.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | — |
| Price-to-Book | — |
| Price-to-Sales (TTM) | — |
| EV/Revenue | - |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | 0 |
| Float | 0 |
| % Insiders | 0.00% |
| % Institutions | 0.00% |
Data last updated: 4/9/2026